Stockreport
Axtria Announces its First Ignite Leadership Award Honorees [Yahoo! Finance]
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
June 18, 2024 /PRNewswire/ -- Axtria, a global leader in cloud software and data analytics for the life sciences industry, has announced the recipients of its first-ever Ignite Leadership Awards, honoring leaders who have demonstrated excellence in driving innovation, transformation, and value creation in their organizations and the industry. This first cohort of annual honorees was presented at the Axtria Ignite 2024 conference, the premier life sciences commercial leaders' event held on June 12 and 13 in Princeton, N.J. "We are thrilled to honor these outstanding leaders with an Ignite Leadership Award, which celebrates their achievements and contributions to the life sciences industry," said Jassi Chadha , CEO and co-founder of Axtria. "Each individual exemplifies the qualities of vision, innovation, transformation, authority, and championing that we value and admire at Axtria." 2024 Ignite Leadership Award Honorees: Arvind Balasundaram , Executive Director, Commercial Insigh
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | REGN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
REGN alerts
REGN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
REGN alerts
High impacting Regeneron Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
REGN
NEWS
NEWS
- Intellia (NTLA) Shares Fall as CFO Glenn Goddard Steps Down [Yahoo! Finance][Yahoo! Finance]
- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $1,152.00 price target on the stock.[MarketBeat]
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN[Accesswire]
- Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine [Yahoo! Finance][Yahoo! Finance]
- Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine[GlobeNewswire]
- More
REGN
SEC Filings
SEC Filings
- 6/25/24 - Form 4
- 6/25/24 - Form 4
- 6/24/24 - Form 144
- REGN's page on the SEC website
- More